Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators

Details for Australian Patent Application No. 2007310624 (hide)

Owner AstraZeneca AB

Inventors Waring, Michael James; Pike, Kurt Gordon; McKerrecher, Darren; Martin, Nathaniel George

Agent Davies Collison Cave

Pub. Number AU-B-2007310624

PCT Pub. Number WO2008/050117

Priority 60/957,370 22.08.07 US; 60/863,056 26.10.06 US

Filing date 25 October 2007

Wipo publication date 2 May 2008

Acceptance publication date 1 September 2011

International Classifications

C07D 241/24 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4439 (2006.01)

A61K 31/497 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/050117 Priority application(s): WO2008/050117

14 May 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name AstraZeneca AB, Application No. 2007310624, under INID (72) correct the name to read McKerrecher, Darren

1 September 2011 Application Accepted

  Published as AU-B-2007310624

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007310626-Photocatalytic reactor

2007310622-Helical stent graft